HU9300537D0 - Polypeptides of human zp3 activity - Google Patents

Polypeptides of human zp3 activity

Info

Publication number
HU9300537D0
HU9300537D0 HU93537A HU53793A HU9300537D0 HU 9300537 D0 HU9300537 D0 HU 9300537D0 HU 93537 A HU93537 A HU 93537A HU 53793 A HU53793 A HU 53793A HU 9300537 D0 HU9300537 D0 HU 9300537D0
Authority
HU
Hungary
Prior art keywords
polypeptides
activity
human
Prior art date
Application number
HU93537A
Other languages
Hungarian (hu)
Other versions
HUT64394A (en
Inventor
Duin Marcel Van
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of HU9300537D0 publication Critical patent/HU9300537D0/en
Publication of HUT64394A publication Critical patent/HUT64394A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9300537A 1990-08-27 1991-08-13 Protein of human zona pellucida zp3 HUT64394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90202287 1990-08-27

Publications (2)

Publication Number Publication Date
HU9300537D0 true HU9300537D0 (en) 1993-05-28
HUT64394A HUT64394A (en) 1993-12-28

Family

ID=8205102

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9300537A HUT64394A (en) 1990-08-27 1991-08-13 Protein of human zona pellucida zp3

Country Status (12)

Country Link
JP (1) JPH06500690A (en)
KR (1) KR930702522A (en)
CN (1) CN1060499A (en)
AU (1) AU8328591A (en)
CA (1) CA2090486A1 (en)
FI (1) FI930897A (en)
HU (1) HUT64394A (en)
IE (1) IE912872A1 (en)
NZ (1) NZ239518A (en)
PT (1) PT98780A (en)
WO (1) WO1992003548A1 (en)
ZA (1) ZA916432B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
CA2096529C (en) * 1990-11-21 2003-01-21 Roy Curtiss, Iii Recombinant avirulent salmonella antifertility vaccines
WO1994010304A1 (en) * 1992-11-02 1994-05-11 Akzo Nobel N.V. Marmoset zona pellucida protein zp3
AU675269B2 (en) * 1992-11-09 1997-01-30 Zonagen, Inc. Materials and methods for immunocontraception
US6001599A (en) * 1992-11-09 1999-12-14 Zonagen, Inc. DNAs encoding mammalian ZPBs
AU3471395A (en) * 1994-08-22 1996-03-14 Akzo Nobel N.V. New immunocontraceptive peptides
DE19622289A1 (en) * 1996-05-23 1997-11-27 Schering Ag Zona Pellucida Proteins for contraception
US7037663B2 (en) * 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
ES2234274T3 (en) * 1998-02-19 2005-06-16 Eastern Virginia Medical School PROTEIN 3 ACTIVE RECOMBINANT OF THE HUMAN HAIR AREA (HZP3).
US7148021B2 (en) 2001-08-02 2006-12-12 Eastern Virginia Meical School Human zona pellucida proteins and methods of their use in diagnosing male infertility
CN101906163B (en) * 2009-06-05 2012-06-27 上海交通大学医学院 Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof
US20210317165A1 (en) * 2018-09-03 2021-10-14 Laboratoire Hra-Pharma Zp3 fragments in immunotherapy of ovarian cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
EP0477226A4 (en) * 1989-06-12 1992-09-30 Us Health Contraceptive vaccine based on cloned zona pellucida gene

Also Published As

Publication number Publication date
JPH06500690A (en) 1994-01-27
ZA916432B (en) 1992-06-24
FI930897A0 (en) 1993-02-26
AU8328591A (en) 1992-03-17
KR930702522A (en) 1993-09-09
WO1992003548A1 (en) 1992-03-05
CA2090486A1 (en) 1992-02-28
PT98780A (en) 1992-07-31
NZ239518A (en) 1994-03-25
FI930897A (en) 1993-04-05
HUT64394A (en) 1993-12-28
CN1060499A (en) 1992-04-22
IE912872A1 (en) 1992-03-11

Similar Documents

Publication Publication Date Title
GB9001952D0 (en) Skin cosmetics
AP9000234A0 (en) Therapeutic nucleocides
HK94994A (en) Skin care compositions
EP0424033A3 (en) External skin preparation
PL284665A1 (en) Apparatus facilitating displacement of human body
HU9300537D0 (en) Polypeptides of human zp3 activity
EP0551084A3 (en) Human antithrombin-iii preparation
GB8503654D0 (en) Human skin substitute
GB9222260D0 (en) Skin treatment
GB2228872B (en) Skin exciser
GB8804531D0 (en) Skin treatment formulations
HU9202431D0 (en) Medical preparatives of local application
ZA914435B (en) Treatment of disease
EP0413721A4 (en) Human gm-csf variants
JPS6461498A (en) Thymopoietin of human being
GB2220652B (en) Treatment of pastures
GB8917406D0 (en) Therapeutic aid
GB9027449D0 (en) Skin care composition
JPS6410000A (en) Human splenine
GB9025622D0 (en) Structure of sickbed
GB9218773D0 (en) Skin treatment
GB8907372D0 (en) Cleansing of the human body
GB8817878D0 (en) Cleansing human body
GB9005579D0 (en) Control of human periodontal disease
HU896054D0 (en) Preparation of human prouroquinase

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee
DNF4 Restoration of lapsed final protection
DNF4 Restoration of lapsed final protection